Next Article in Journal
Vetiver Essential Oil in Cosmetics: What Is New?
Previous Article in Journal
Synthesis, Antimicrobial, and Antioxidant Activities of Chalcogen-Containing Nitrone Derivatives from (R)-citronellal
Article Menu

Export Article

Open AccessLetter
Medicines 2017, 4(2), 40;

“When the Bug Cannot Be Killed”—The Rising Challenge of Antimicrobial Resistance

Research Unit, Health Policy Consult, P.O. Box WJ 537, Weija-Accra, Ghana
Academic Editor: Gerhard Litscher
Received: 16 May 2017 / Revised: 5 June 2017 / Accepted: 13 June 2017 / Published: 14 June 2017
View Full-Text   |   Download PDF [214 KB, uploaded 14 June 2017]


Antimicrobial resistance is a major global health issue that has the potential to reverse the substantial progress made against infectious diseases over the past several decades. We need strategic measures to deal with this challenge, including an intensification of public funding for research into anti-microbial agents and their alternatives, stricter mechanisms to minimize antimicrobial misuse within both clinical and non-clinical settings, and support for the development of country-level initiatives. Only with sustained, concerted, and coordinated global efforts are we likely to overcome the current and future challenges posed by these emerging “superbugs”. View Full-Text
Keywords: antimicrobial resistance; superbugs; international health antimicrobial resistance; superbugs; international health
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Ofori-Asenso, R. “When the Bug Cannot Be Killed”—The Rising Challenge of Antimicrobial Resistance. Medicines 2017, 4, 40.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Medicines EISSN 2305-6320 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top